3631 results for «949»

Filter By

3631 results

TAVI in bicuspid - Planning to performance

22 May 2026 – From EuroPCR 2026

Dedicated to transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves, this session examines anatomical assessment, sizing methods, and clinical outcomes. It includes meta-analyses and registry insights, addressing challenges such as stent deformation and leaflet modification to guide optimal TAVI performance in this distinct patient population.

Clinical decision making for CTO PCI strategy

22 May 2026 – From EuroPCR 2026

This session explores clinical decision-making in CTO PCI strategy through complex scenarios including multivessel CTO in ischemic cardiomyopathy, high-risk NSTEMI post-vein graft failure, and challenges in elderly patients. It emphasizes strategic planning and individualized approaches to optimize outcomes.

When anatomy surprises: closing rare fistulae

21 May 2026 – From EuroPCR 2026

This session focuses on the percutaneous closure of rare and complex cardiac fistulae and related vascular anomalies. It presents diverse cases such as superior vena cava syndrome from pacemaker leads, iatrogenic aorta-to-left atrium fistula, and unusual cardio-pulmonary connections, illustrating advanced interventional techniques to address unexpected anatomical...

Spectrum of cardiogenic shock

21 May 2026 – From EuroPCR 2026

This session delves into the broad spectrum of cardiogenic shock phenotypes, emphasizing the importance of selecting appropriate left ventricular support tailored to specific clinical scenarios. It offers critical insights into the timing of mechanical circulatory support and revascularisation strategies to optimize patient outcomes.

Bifurcation and heavily calcified lesions

21 May 2026 – From EuroPCR 2026

This session addresses the evaluation and treatment of bifurcation and heavily calcified coronary lesions. It includes case-based discussions on complex left main PCI and the use of drug-coated balloons (DCB) for bifurcation lesions and in-stent restenosis, providing evidence-based approaches to optimize outcomes in these challenging lesion...

Complication management during STEMI intervention: Czech Republic - Greece and Iraq present their cases

21 May 2026 – From EuroPCR 2026

This session presents a critical analysis of procedural strategies in primary PCI for STEMI by exploring complex cases from the Czech Republic, Greece, and Iraq. It delves into mechanisms and management of major PCI complications and highlights the role of emerging novel technologies in primary PCI...

Complication management after tricuspid valve interventions

21 May 2026 – From EuroPCR 2026

This session reviews complication management following tricuspid valve interventions, highlighting practical approaches to unexpected procedural events. Topics include management of TricValve pop-up complications, Evoque device challenges, acute leaflet thrombosis emergencies, and bailout strategies for single leaflet detachment in tricuspid transcatheter edge-to-edge repair (TEER).

Addressing difficult anatomy in STEMI patients

21 May 2026 – From EuroPCR 2026

This session addresses the challenges of managing difficult coronary anatomy in STEMI patients through a series of complex case studies. Topics include management of aneurysms, rare aorto-ostial lesions, thrombosis interplay, PPCI in dextrocardia situs inversus, and hybrid PCI approaches for multifaceted coronary issues.

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

COVID-19 vaccines: Burning questions from the community and real-world applicability

13 Jan 2021

View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.

COVID-19 vaccines: Burning questions from the community and real-world applicability

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?